ChromaTan is an innovator in improving efficiencies and reducing costs of Biotechnology processes.
Total raised: $2M
Investors 6
Date | Name | Website |
- | MassChalle... | masschalle... |
- | BlueTree A... | bluetreeal... |
- | Ben Frankl... | sep.benfra... |
- | Life Scien... | lsgpa.com |
- | BlueTree V... | bluetreeve... |
- | Lehigh Val... | lehighvall... |
Funding Rounds 1
Date | Series | Amount | Investors |
31.05.2024 | Grant | $2M | - |
Mentions in press and media 21
Date | Title | Description |
31.05.2024 | ChromaTan Receives a $2M Phase IIB NIH Grant | The single-use, columnless, steady state continuous elution chromatography platform (Photo: Business Wire) ChromaTan, a Lower Gwynedd, PA-based bioprocessing and biotools biomanufacturing technology platform development company, received a ... |
11.12.2020 | News briefing: CG Oncology nets $47M Series D for bladder cancer studies; Single-cell transcriptomic startup raises $24M launch cash | CG Oncology has some new cash to play with. The Irvine, CA-based biotech announced Thursday it closed a $47 million Series D round of preferred stock financing as the company continues to advance late-stage trials for its le... |
02.12.2020 | News briefing: Exelixis pays $20M to in-license a preclinical ADC for the pipeline; Another preclinical biotech shoots for a big IPO | Eighteen months after Exelixis signed on to partner with Iconic Therapeutics on an antibody-drug conjugate, more money is flowing. Exelixis is picking up its exclusive option on the tissue factor-targeting ADC now k... |
12.11.2020 | News briefing: Small merger to advance anti-aging program; Sanger Institute spinout nabs $50M from Series C | Small-cap player Akers Biosciences $AKER has engineered a reverse merger with private company MyMD Pharmaceuticals. The new combined biotech, which will retain the name MyMD, is expected to trade under the new ticker $M... |
06.11.2020 | News briefing: Chinese cancer player gets $124M+ Series C; IN8bio sets terms for $86M IPO | A little less than two years after a nine-figure Series B, Apollomics has returned to the venture well. This time, the company has come out with even more money, pulling in $124.2 million for a Series C round. The funding will ... |
19.10.2020 | News briefing: AbbVie and Roche's Venclexta scores another FDA OK; ImmunoGen nabs China deal with $40M cash | AbbVie and Roche’s Venclexta has gotten a new FDA thumbs up. The pair announced Monday that regulators have approved the drug in combination with azacitidine or low-dose cytarabine for newly-diagnosed acute myeloid leu... |
14.04.2020 | Will, Italy’s Instagram-born news startup, raises €1.2 million and launches podcast | Will, the first Italian Instagram-born community for generations interested in becoming more aware of the world around them, has closed a €1.2 million seed round. The lead investors are Davide Dattoli (Founder and CEO of Talent Garden), Fra... |
12.11.2019 | Ben Franklin Approved 1M+ in 6 Early Stage Companies | |
04.04.2019 | Cash-hungry news app Qutoutiao raises another USD 33m via public offering | China’s No. 2 mobile content aggregator Qutoutiao has sold approximately 3.3 million American Depositary Shares in a public offering at USD 10 apiece, an 8% discount compared with the closing price on the previous trading day, its prospectu... |
02.04.2019 | News aggregator KidzByte raises $290K in seed funding | KidzByte MediaTech Pvt. Ltd, a Mumbai-based news aggregator for children, said it has raised Rs 2 crore ($290,000 at current exchange rate) in seed investment from entrepreneur Pranay Goyal. Key investor Pranay Goyal is the managing directo... |
Show more